Morishita Jintan Co., Ltd. (TYO:4524)

Japan · Delayed Price · Currency is JPY

2,238.00

-5.00 (-0.22%)

Sep 14, 2026, 2:56 PM JST

Market Cap	9.17B +0.9%
Revenue (ttm)	12.82B +1.0%
Net Income	789.00M +69.7%
EPS	192.54 +69.4%
Shares Out	4.10M
PE Ratio	11.62
Forward PE	n/a
Dividend	65.00 (2.89%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,400
Open	2,243.00
Previous Close	2,243.00
Day's Range	2,236.00 - 2,245.00
52-Week Range	2,100.00 - 2,390.00
Beta	0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About Morishita Jintan

Morishita Jintan Co., Ltd. manufactures and sale of pharmaceuticals, quasi-drugs, and health food in Japan. The company offers health food products, oral care products, and medical supplies under the JINTAN brand. It also sells health food, medicines, food, and miscellaneous goods, as well as other company's products through phone/postcard/online shops; cosmetics, domestic products through department stores, drugstores, convenience stores, volume sellers, and supermarkets; and BabyD 200, Bifidus HD, and Bifidobacterium Pearl products through me... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1893

Employees 359

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 4524

Full Company Profile

Financial Performance

In fiscal year 2026, Morishita Jintan's revenue was 12.69 billion, a decrease of -0.61% compared to the previous year's 12.77 billion. Earnings were 628.00 million, an increase of 14.81%.

Financial Statements